Welcome to the AGA Self-Assessment Module (SAM) on geriatric gastroenterology and hepatology. Originally authored in 2015, the content was reviewed in April 2020 and updated to match current scientific knowledge.
We’re excited to re-offer this very popular learning module for your use in studying and staying current. We believe SAMs represents a unique contribution to your continuing medical education.
Certainly, the current shift in practice demographics makes it imperative to be familiar with the special needs and considerations of the aging population. The questions were written to reflect a variety of learning objectives, including common issues in geriatrics which intersect clinical encounters with gastroenterologists and hepatologists, the modulation of our diagnostic and therapeutic approaches in this special population, and conditions which represent a heightened vulnerability for the aged. This module should serve all learners as a useful exercise for identifying any current knowledge gaps and providing the resources for self-directed learning. The module questions were written in a boards-style format, with a high level of review for content and function and serve to provide excellent practice for your board exam review in a focused area of gastroenterology and internal medicine.
Sign in to access [Member Only]
After you sign in, please click the "Launch" button on the top of this page to access the course.
Learning objectives
- Differentiate changes in the oral cavity associated with aging versus disease.
- Manage upper GI symptoms in a patient with enteral feeding.
- Develop an approach to the elderly patient with undernutrition.
- Apply changes associated with aging that increase risk of nonsteroidal anti-inflammatory drug (NSAID) related complications in the elderly.
- Recognize safe medications for conscious sedation in elderly patients.
- Identify medications commonly used in the elderly which can cause diarrhea.
- Screen for common conditions associated with care of the elderly post-transplant liver patient.
Faculty
Editors:
Arthur J. DeCross, MD, AGAF
Amy S. Oxentenko, MD, AGAF, FACP, FACG
Authors:
Brijen J. Shah, MD
Michele Young, MD
Pricing
| Member | Nonmember |
|---|---|
| $Free |
Not available to nonmembers (member only) |
Accreditation and designation
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this enduring material activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC statement
Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MOC/CME expiration date: April 30, 2021
The following disclosures were presented by faculty and staff at the time this SAM was authored.
Arthur J. DeCross, MD, AGAF
Disclosed no relevant financial relationships
C. Prakash Gyawali, MD, MRCP, AGAF
Advisory Committee: Abbvie
Consulting: Covidien, Abbvie
Grant/Research support: Given Imaging
Speaking and Teaching: Forrest/Ironwood, Abbvie
Jonathan C. Huang, DO
Disclosed no relevant financial relationships
Amy S. Oxentenko, MD, AGAF, FACP, FACG
Disclosed no relevant financial relationships
Brijen J. Shah, MD
Disclosed no relevant financial relationships
Sonia S. Yoon, MD
Disclosed no relevant financial relationships
Michele Young, MD
Disclosed no relevant financial relationships
Planning Committee
Arthur J. DeCross, MD, AGAF
Disclosed no relevant financial relationships
Jane E. Onken, MD, MHS, AGAF
Member: BMS DMC
Major Stock Shareholder: Merck
Suzanne Rose, MD, MSEd, AGAF
Major Stock Shareholder: Abbott Labs, Baxter International, Johnson & Johnson, Novo Nordisk, Perrigo
Advisory Committees or Review Panels: AAMC
AGA Staff
Maura H. Davis
Disclosed no relevant financial relationships
Curricula Resources
APPs, Patient care physicians, Trainees, Training directors/GI division chiefs
Time to Complete: 4.5 hours
Released: May 18, 2020
Expires: April 30, 2021